Total Payments
$197,706
2024 Payments
$255.31
Companies
14
Transactions
124
Medicare Patients
758
Medicare Billing
$172,907
Payment Breakdown by Category
Consulting$141,325 (71.5%)
Other$46,263 (23.4%)
Research$5,833 (3.0%)
Travel$3,051 (1.5%)
Food & Beverage$978.87 (0.5%)
Education$255.31 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $141,325 | 21 | 71.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $45,263 | 13 | 22.9% |
| Unspecified | $5,833 | 12 | 3.0% |
| Travel and Lodging | $3,051 | 14 | 1.5% |
| Honoraria | $1,000 | 1 | 0.5% |
| Food and Beverage | $978.87 | 43 | 0.5% |
| Education | $255.31 | 20 | 0.1% |
Payments by Type
General
$191,873
112 transactions
Research
$5,833
12 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $131,571 | 28 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $46,788 | 46 | $0 (2024) |
| UCB SA | $9,675 | 5 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $4,833 | 10 | $0 (2019) |
| Jazz Pharmaceuticals Inc. | $4,060 | 2 | $0 (2020) |
| Medtronic USA, Inc. | $631.24 | 23 | $0 (2019) |
| Philips Electronics North America Corporation | $27.99 | 2 | $0 (2023) |
| US WorldMeds, LLC | $24.86 | 2 | $0 (2017) |
| AbbVie, Inc. | $24.06 | 1 | $0 (2017) |
| GE Healthcare | $15.40 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $255.31 | 20 | ACADIA Pharmaceuticals Inc ($155.85) |
| 2023 | $12.81 | 1 | Philips Electronics North America Corporation ($12.81) |
| 2022 | $15.18 | 1 | Philips Electronics North America Corporation ($15.18) |
| 2020 | $8,110 | 5 | Jazz Pharmaceuticals Inc. ($4,060) |
| 2019 | $11,538 | 19 | UCB SA ($5,625) |
| 2018 | $16,152 | 15 | Teva Pharmaceuticals USA, Inc. ($9,500) |
| 2017 | $161,624 | 63 | Teva Pharmaceuticals USA, Inc. ($121,972) |
All Payment Transactions
124 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/14/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/09/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/26/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/20/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/12/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/07/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/16/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $9.36 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/16/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/16/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $4.54 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/24/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/31/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/28/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $99.46 | General |
| 05/21/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/06/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/19/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/07/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/27/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/16/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/01/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 01/04/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/17/2023 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $12.81 | General |
| Category: Medical Device | ||||||
| 04/01/2022 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $15.18 | General |
| Category: Medical Device | ||||||
| 04/30/2020 | UCB SA | — | Consulting Fee | Cash or cash equivalent | $1,350.00 | General |
| 03/04/2020 | UCB SA | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 01/28/2020 | Jazz Pharmaceuticals Inc. | — | Travel and Lodging | Cash or cash equivalent | $59.84 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, PLACEBO SURGERY CONTROLLED, DOUBLE-BLINDED, MULTI-CENTER, PHASE 2 CLINICAL TRIAL, EVALUATING THE EFFICACY AND SAFETY OF VY-AADC02 IN ADVANCED PARKINSON'S DISEASE WITH MOTOR FLUCTUATIONS | Neurocrine Biosciences, Inc. | $4,833 | 10 |
| ACA 16-cAC-0001 | ACADIA Pharmaceuticals Inc | $1,000 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 154 | 221 | $103,550 | $29,701 |
| 2022 | 3 | 164 | 238 | $109,986 | $33,285 |
| 2021 | 4 | 191 | 256 | $103,596 | $33,451 |
| 2020 | 6 | 249 | 9,491 | $223,851 | $76,470 |
Total Patients
758
Total Services
10,206
Medicare Billing
$172,907
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 107 | 172 | $77,400 | $23,642 | 30.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $16,550 | $3,940 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 24 | $9,600 | $2,120 | 22.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 107 | 174 | $76,515 | $24,886 | 32.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 29 | 29 | $18,743 | $5,104 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 35 | $14,728 | $3,295 | 22.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 110 | 162 | $64,038 | $23,169 | 36.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 32 | 32 | $18,097 | $5,444 | 30.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 45 | $18,459 | $4,107 | 22.3% |
| 95971 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with simple spinal cord or peripheral nerve stimulator programming | Office | 2021 | 12 | 17 | $3,002 | $729.94 | 24.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 13 | 9,160 | $109,920 | $42,569 | 38.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 112 | 179 | $66,946 | $20,186 | 30.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 63 | 81 | $22,761 | $6,346 | 27.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 29 | 29 | $15,544 | $4,413 | 28.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 17 | 17 | $4,530 | $1,916 | 42.3% |
| 95971 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with simple spinal cord or peripheral nerve stimulator programming | Office | 2020 | 15 | 25 | $4,150 | $1,040 | 25.1% |
About Dr. Andrew Mcgarry, M.D
Dr. Andrew Mcgarry, M.D is a Neurology healthcare provider based in Cherry Hill, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902818610.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Mcgarry, M.D has received a total of $197,706 in payments from pharmaceutical and medical device companies, with $255.31 received in 2024. These payments were reported across 124 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($141,325).
As a Medicare-enrolled provider, Mcgarry has provided services to 758 Medicare beneficiaries, totaling 10,206 services with total Medicare billing of $172,907. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Cherry Hill, NJ
- Active Since 08/12/2006
- Last Updated 11/10/2014
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1902818610
Products in Payments
- PRIDOPIDINE (Drug) $104,899
- NUPLAZID (Drug) $46,788
- AUSTEDO (Drug) $5,148
- ACTIVA (Device) $612.07
- SD809-HD (Drug) $38.58
- (5044) MCOT (Device) $27.99
- Zinbryta (Biological) $24.06
- Solitaire (Device) $19.17
- APTIOM (Drug) $14.66
- TYSABRI (Biological) $14.25
- Xadago (Drug) $13.92
- BOTOX THERAPEUTIC (Biological) $13.39
- INBRIJA (Drug) $12.92
- APOKYN (Drug) $10.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Cherry Hill
Dr. Keith Preis, M.d, M.D
Neurology — Payments: $37,602
Neurology $37,602
Yiwen Shi, Md, MD
Neurology — Payments: $24,735
Neurology $24,735
Larry Janoff, Do, DO
Neurology — Payments: $13,318
Neurology $13,318
Dr. Russell Abrams, M.d, M.D
Neurology — Payments: $11,711
Neurology $11,711
Ryan Devenyi, Md, MD
Neurology — Payments: $9,315
Neurology $9,315
Allen Zechowy, Md, MD
Neurology — Payments: $7,014
Neurology $7,014